Antihypertensive Drugs Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Antihypertensive Drugs Market to 2027 - Global Analysis and Forecasts By Therapeutics (Diuretics, Angiotensin Receptor Blockers (Arbs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators); Distribution Channels (Hospital Pharmacy, Retail Pharmacy, E-Commerce Websites, Online Drug Stores) and Geography

Report Code: TIPRE00003746 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Antihypertensive drugs are used to treat hypertension and to prevent the complication of high blood pressure. Hypertension is a medical condition where the blood pressure in the arteries is persistently high. High blood pressure increases the risk of heart failure, ischaemic heart diseases stroke, and death. Hypertension also leads to some other problems such as renal impairment, visual impairment and retinal hemorrhage. Antihypertensive drugs are consumed by the patients (once a day) in a low dose. However. side effects associated with these drugs are usually minor.

MARKET DYNAMICS
The antihypertensive drugs market is expected to grow in coming years owing to factors such as increase in number of patients suffering from hypertension, change in lifestyle such as food habits, increasing penetration of generic versions of drugs and growing prevalence of chronic diseases. Also the launch of novel drug therapy with improved efficacy and safety and patent expiration of blockbuster drug has offered new opportunities for market growth.

MARKET SCOPE
The "Global Antihypertensive Drugs Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of antihypertensive drugs market with detailed market segmentation by therapeutics, distribution channel and geography. The global antihypertensive drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading antihypertensive drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global antihypertensive drugs market is segmented on the basis of therapeutics and distribution channel. Based on therapeutics, the market is segmented as diuretics, angiotensin receptor blockers (ARBS), angiotensin converting enzyme (ACE) inhibitors, beta blockers, alpha blockers, calcium channel blockers, renin inhibitors and vasodilators. Based on distribution channel the antihypertensive drugs market is segmented as hospital pharmacy, retail pharmacy, e-commerce websites and online drug stores.


REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global antihypertensive drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The antihypertensive drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting antihypertensive drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the antihypertensive drugs market in these regions.


MARKET PLAYERS
The reports cover key developments in the antihypertensive drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from antihypertensive drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for antihypertensive drugs in the global market. Below mentioned is the list of few companies engaged in the c market.

The report also includes the profiles of key antihypertensive drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  • Pfizer Inc.
  • Novartis AG
  • Sanofi.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH.
  • LUPIN.
  • Johnson & Johnson Services, Inc.
  • AstraZeneca
  • DAIICHI SANKYO COMPANY, LIMITED.
  • Ranbaxy Laboratories Limited, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
 1.1. SCOPE OF THE STUDY
 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
 1.3. MARKET SEGMENTATION
 1.3.1 Antihypertensive Drugs Market - By Therapeutics
 1.3.2 Antihypertensive Drugs Market - By Distribution Channels
 1.3.3 Antihypertensive Drugs Market - By Region
 1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ANTIHYPERTENSIVE DRUGS MARKET LANDSCAPE
 4.1. OVERVIEW
 4.2. PEST ANALYSIS
 4.2.1 North America - Pest Analysis
 4.2.2 Europe - Pest Analysis
 4.2.3 Asia-Pacific - Pest Analysis
 4.2.4 Middle East and Africa - Pest Analysis
 4.2.5 South and Central America - Pest Analysis
 4.3. EXPERT OPINIONS

5. ANTIHYPERTENSIVE DRUGS MARKET - KEY MARKET DYNAMICS
 5.1. KEY MARKET DRIVERS
 5.2. KEY MARKET RESTRAINTS
 5.3. KEY MARKET OPPORTUNITIES
 5.4. FUTURE TRENDS
 5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. ANTIHYPERTENSIVE DRUGS MARKET - GLOBAL MARKET ANALYSIS
 6.1. ANTIHYPERTENSIVE DRUGS - GLOBAL MARKET OVERVIEW
 6.2. ANTIHYPERTENSIVE DRUGS - GLOBAL MARKET AND FORECAST TO 2027
 6.3. MARKET POSITIONING/MARKET SHARE

7. ANTIHYPERTENSIVE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - THERAPEUTICS
 7.1. OVERVIEW
 7.2. THERAPEUTICS MARKET FORECASTS AND ANALYSIS
 7.3. DIURETICS
 7.3.1. Overview
 7.3.2. Diuretics Market Forecast and Analysis
 7.4. ANGIOTENSIN RECEPTOR BLOCKERS (ARBS)
 7.4.1. Overview
 7.4.2. Angiotensin receptor blockers (ARBs) Market Forecast and Analysis
 7.5. ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS
 7.5.1. Overview
 7.5.2. Angiotensin converting enzyme (ACE) inhibitors Market Forecast and Analysis
 7.6. BETA BLOCKERS
 7.6.1. Overview
 7.6.2. Beta Blockers Market Forecast and Analysis
 7.7. ALPHA BLOCKERS
 7.7.1. Overview
 7.7.2. Alpha Blockers Market Forecast and Analysis
 7.8. CALCIUM CHANNEL BLOCKERS
 7.8.1. Overview
 7.8.2. Calcium Channel Blockers Market Forecast and Analysis
 7.9. RENIN INHIBITORS
 7.9.1. Overview
 7.9.2. Renin Inhibitors Market Forecast and Analysis
 7.10. VASODILATORS
 7.10.1. Overview
 7.10.2. Vasodilators Market Forecast and Analysis

8. ANTIHYPERTENSIVE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNELS
 8.1. OVERVIEW
 8.2. DISTRIBUTION CHANNELS MARKET FORECASTS AND ANALYSIS
 8.3. HOSPITAL PHARMACY
 8.3.1. Overview
 8.3.2. Hospital Pharmacy Market Forecast and Analysis
 8.4. RETAIL PHARMACY
 8.4.1. Overview
 8.4.2. Retail Pharmacy Market Forecast and Analysis
 8.5. E-COMMERCE WEBSITES
 8.5.1. Overview
 8.5.2. e-commerce Websites Market Forecast and Analysis
 8.6. ONLINE DRUG STORES
 8.6.1. Overview
 8.6.2. Online Drug Stores Market Forecast and Analysis

9. ANTIHYPERTENSIVE DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
 9.1. NORTH AMERICA
 9.1.1 North America Antihypertensive Drugs Market Overview
 9.1.2 North America Antihypertensive Drugs Market Forecasts and Analysis
 9.1.3 North America Antihypertensive Drugs Market Forecasts and Analysis - By Therapeutics
 9.1.4 North America Antihypertensive Drugs Market Forecasts and Analysis - By Distribution Channels
 9.1.5 North America Antihypertensive Drugs Market Forecasts and Analysis - By Countries
 9.1.5.1 United States Antihypertensive Drugs Market
 9.1.5.1.1 United States Antihypertensive Drugs Market by Therapeutics
 9.1.5.1.2 United States Antihypertensive Drugs Market by Distribution Channels
 9.1.5.2 Canada Antihypertensive Drugs Market
 9.1.5.2.1 Canada Antihypertensive Drugs Market by Therapeutics
 9.1.5.2.2 Canada Antihypertensive Drugs Market by Distribution Channels
 9.1.5.3 Mexico Antihypertensive Drugs Market
 9.1.5.3.1 Mexico Antihypertensive Drugs Market by Therapeutics
 9.1.5.3.2 Mexico Antihypertensive Drugs Market by Distribution Channels
 9.2. EUROPE
 9.2.1 Europe Antihypertensive Drugs Market Overview
 9.2.2 Europe Antihypertensive Drugs Market Forecasts and Analysis
 9.2.3 Europe Antihypertensive Drugs Market Forecasts and Analysis - By Therapeutics
 9.2.4 Europe Antihypertensive Drugs Market Forecasts and Analysis - By Distribution Channels
 9.2.5 Europe Antihypertensive Drugs Market Forecasts and Analysis - By Countries
 9.2.5.1 Germany Antihypertensive Drugs Market
 9.2.5.1.1 Germany Antihypertensive Drugs Market by Therapeutics
 9.2.5.1.2 Germany Antihypertensive Drugs Market by Distribution Channels
 9.2.5.2 France Antihypertensive Drugs Market
 9.2.5.2.1 France Antihypertensive Drugs Market by Therapeutics
 9.2.5.2.2 France Antihypertensive Drugs Market by Distribution Channels
 9.2.5.3 Italy Antihypertensive Drugs Market
 9.2.5.3.1 Italy Antihypertensive Drugs Market by Therapeutics
 9.2.5.3.2 Italy Antihypertensive Drugs Market by Distribution Channels
 9.2.5.4 Spain Antihypertensive Drugs Market
 9.2.5.4.1 Spain Antihypertensive Drugs Market by Therapeutics
 9.2.5.4.2 Spain Antihypertensive Drugs Market by Distribution Channels
 9.2.5.5 United Kingdom Antihypertensive Drugs Market
 9.2.5.5.1 United Kingdom Antihypertensive Drugs Market by Therapeutics
 9.2.5.5.2 United Kingdom Antihypertensive Drugs Market by Distribution Channels
 9.3. ASIA-PACIFIC
 9.3.1 Asia-Pacific Antihypertensive Drugs Market Overview
 9.3.2 Asia-Pacific Antihypertensive Drugs Market Forecasts and Analysis
 9.3.3 Asia-Pacific Antihypertensive Drugs Market Forecasts and Analysis - By Therapeutics
 9.3.4 Asia-Pacific Antihypertensive Drugs Market Forecasts and Analysis - By Distribution Channels
 9.3.5 Asia-Pacific Antihypertensive Drugs Market Forecasts and Analysis - By Countries
 9.3.5.1 Australia Antihypertensive Drugs Market
 9.3.5.1.1 Australia Antihypertensive Drugs Market by Therapeutics
 9.3.5.1.2 Australia Antihypertensive Drugs Market by Distribution Channels
 9.3.5.2 China Antihypertensive Drugs Market
 9.3.5.2.1 China Antihypertensive Drugs Market by Therapeutics
 9.3.5.2.2 China Antihypertensive Drugs Market by Distribution Channels
 9.3.5.3 India Antihypertensive Drugs Market
 9.3.5.3.1 India Antihypertensive Drugs Market by Therapeutics
 9.3.5.3.2 India Antihypertensive Drugs Market by Distribution Channels
 9.3.5.4 Japan Antihypertensive Drugs Market
 9.3.5.4.1 Japan Antihypertensive Drugs Market by Therapeutics
 9.3.5.4.2 Japan Antihypertensive Drugs Market by Distribution Channels
 9.3.5.5 South Korea Antihypertensive Drugs Market
 9.3.5.5.1 South Korea Antihypertensive Drugs Market by Therapeutics
 9.3.5.5.2 South Korea Antihypertensive Drugs Market by Distribution Channels
 9.4. MIDDLE EAST AND AFRICA
 9.4.1 Middle East and Africa Antihypertensive Drugs Market Overview
 9.4.2 Middle East and Africa Antihypertensive Drugs Market Forecasts and Analysis
 9.4.3 Middle East and Africa Antihypertensive Drugs Market Forecasts and Analysis - By Therapeutics
 9.4.4 Middle East and Africa Antihypertensive Drugs Market Forecasts and Analysis - By Distribution Channels
 9.4.5 Middle East and Africa Antihypertensive Drugs Market Forecasts and Analysis - By Countries
 9.4.5.1 South Africa Antihypertensive Drugs Market
 9.4.5.1.1 South Africa Antihypertensive Drugs Market by Therapeutics
 9.4.5.1.2 South Africa Antihypertensive Drugs Market by Distribution Channels
 9.4.5.2 Saudi Arabia Antihypertensive Drugs Market
 9.4.5.2.1 Saudi Arabia Antihypertensive Drugs Market by Therapeutics
 9.4.5.2.2 Saudi Arabia Antihypertensive Drugs Market by Distribution Channels
 9.4.5.3 U.A.E Antihypertensive Drugs Market
 9.4.5.3.1 U.A.E Antihypertensive Drugs Market by Therapeutics
 9.4.5.3.2 U.A.E Antihypertensive Drugs Market by Distribution Channels
 9.5. SOUTH AND CENTRAL AMERICA
 9.5.1 South and Central America Antihypertensive Drugs Market Overview
 9.5.2 South and Central America Antihypertensive Drugs Market Forecasts and Analysis
 9.5.3 South and Central America Antihypertensive Drugs Market Forecasts and Analysis - By Therapeutics
 9.5.4 South and Central America Antihypertensive Drugs Market Forecasts and Analysis - By Distribution Channels
 9.5.5 South and Central America Antihypertensive Drugs Market Forecasts and Analysis - By Countries
 9.5.5.1 Brazil Antihypertensive Drugs Market
 9.5.5.1.1 Brazil Antihypertensive Drugs Market by Therapeutics
 9.5.5.1.2 Brazil Antihypertensive Drugs Market by Distribution Channels
 9.5.5.2 Argentina Antihypertensive Drugs Market
 9.5.5.2.1 Argentina Antihypertensive Drugs Market by Therapeutics
 9.5.5.2.2 Argentina Antihypertensive Drugs Market by Distribution Channels

10. INDUSTRY LANDSCAPE
 10.1. MERGERS AND ACQUISITIONS
 10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
 10.3. NEW PRODUCT LAUNCHES
 10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. ANTIHYPERTENSIVE DRUGS MARKET, KEY COMPANY PROFILES
 11.1. PFIZER INC.
 11.1.1. Key Facts
 11.1.2. Business Description
 11.1.3. Products and Services
 11.1.4. Financial Overview
 11.1.5. SWOT Analysis
 11.1.6. Key Developments
 11.2. NOVARTIS AG
 11.2.1. Key Facts
 11.2.2. Business Description
 11.2.3. Products and Services
 11.2.4. Financial Overview
 11.2.5. SWOT Analysis
 11.2.6. Key Developments
 11.3. SANOFI.
 11.3.1. Key Facts
 11.3.2. Business Description
 11.3.3. Products and Services
 11.3.4. Financial Overview
 11.3.5. SWOT Analysis
 11.3.6. Key Developments
 11.4. MERCK & CO., INC.
 11.4.1. Key Facts
 11.4.2. Business Description
 11.4.3. Products and Services
 11.4.4. Financial Overview
 11.4.5. SWOT Analysis
 11.4.6. Key Developments
 11.5. BOEHRINGER INGELHEIM INTERNATIONAL GMBH.
 11.5.1. Key Facts
 11.5.2. Business Description
 11.5.3. Products and Services
 11.5.4. Financial Overview
 11.5.5. SWOT Analysis
 11.5.6. Key Developments
 11.6. LUPIN.
 11.6.1. Key Facts
 11.6.2. Business Description
 11.6.3. Products and Services
 11.6.4. Financial Overview
 11.6.5. SWOT Analysis
 11.6.6. Key Developments
 11.7. JOHNSON & JOHNSON SERVICES, INC.
 11.7.1. Key Facts
 11.7.2. Business Description
 11.7.3. Products and Services
 11.7.4. Financial Overview
 11.7.5. SWOT Analysis
 11.7.6. Key Developments
 11.8. ASTRAZENECA
 11.8.1. Key Facts
 11.8.2. Business Description
 11.8.3. Products and Services
 11.8.4. Financial Overview
 11.8.5. SWOT Analysis
 11.8.6. Key Developments
 11.9. DAIICHI SANKYO COMPANY, LIMITED.
 11.9.1. Key Facts
 11.9.2. Business Description
 11.9.3. Products and Services
 11.9.4. Financial Overview
 11.9.5. SWOT Analysis
 11.9.6. Key Developments
 11.10. RANBAXY LABORATORIES LIMITED, INC.
 11.10.1. Key Facts
 11.10.2. Business Description
 11.10.3. Products and Services
 11.10.4. Financial Overview
 11.10.5. SWOT Analysis
 11.10.6. Key Developments

12. APPENDIX
 12.1. ABOUT THE INSIGHT PARTNERS
 12.2. GLOSSARY OF TERMS

 

The List of Companies

1. Pfizer Inc.
2. Novartis AG
3. Sanofi.
4. Merck & Co. , Inc.
5. Boehringer Ingelheim International GmbH.
6. LUPIN.
7. Johnson & Johnson Services, Inc.
8. AstraZeneca
9. DAIICHI SANKYO COMPANY, LIMITED.
10. Ranbaxy Laboratories Limited, Inc.